Podcast appearances and mentions of milan bicocca

durée : 00:58:36 - Cultures Monde - par : Julie Gacon, Mélanie Chalandon - Dans les années 1960, la "Révolution verte" a instauré en Inde une agriculture intensive, centrée autour du riz et du blé. Désastre environnemental et social, quelles sont les limites de ce modèle, inchangé depuis 70 ans ? Quel est le poids des questions agricoles dans les élections à venir ? - invités : Julie Jacquet Doctorante en géographie à l'Université Paris-Nanterre, enseignante à l'Inalco; David Singh Chercheur en sciences politique à l'Université de Copenhague ; Floriane Bolazzi Chercheuse en socio-économie à l'Université de Milan-Bicocca

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for VTE treatment in patients with cancer and evaluating direct factor Xa inhibitors for extended postoperative prophylaxis. Based on this new evidence, they present updated evidence-based recommendations from the guideline expert panel. Dr. Key and Dr. Falanga also discuss outstanding questions regarding VTE prophylaxis and treatment in patients with cancer. Read the full guideline update, “Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Guideline Update” at www.asco.org/supportive-care-guidelines. TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/supportive-care-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest disclosures in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO.23.00294.  Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one at ASCO.org/podcasts.  My name is Brittany Harvey, and today I'm interviewing Dr. Nigel Key from University of North Carolina, and Dr. Anna Falanga from University of Milan Bicocca, co-chairs on ‘Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Guideline Update'.  Thank you for being here, Dr. Key, and Dr. Falanga.  Dr. Nigel Key: Thank you.  Dr. Falanga: Thank you. Brittany Harvey: Then, before we discuss this guideline, I'd just like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including our guests on this episode, are available online with the publication of the guideline in the Journal of Clinical Oncology, linked in the show notes.  So then, jumping into this guideline update, Dr. Key, what prompted an update to the ‘ASCO VTE Guideline', which was last updated in 2019?  Dr. Nigel Key: Okay, well, thank you, Brittany, for that question. Well, first of all, ASCO has been providing this guideline since 2007 with iterations and full reviews of the data, the last complete one being in 2019. This update was really triggered by ASCO's signals approach, which relies on experts in the field suggesting an update to the guidelines based on recent publications that may be practice-changing. So, in this case, the signals were really a randomized control trial assessing apixaban for VTE treatment, venous thromboembolism treatment, in patients with cancer called the CARAVAGGIO trial, and we'll discuss that a little bit later. There were also a couple of randomized control trials which evaluated direct factor Xa inhibitors for extended postoperative prophylaxis, and these were new areas subsequent to the 2019 guidelines. So, a systematic review was carried out in the relevant topics for randomized control trials published between November 1, 2018, and June 6, 2022. And what you'll hear today is the result of that process.  Brittany Harvey: Great. And then you just described that guideline recommendations were updated both for prophylaxis and for treatment. So then, Dr. Falanga, what is the updated recommendation for perioperative VTE prophylaxis? Dr. Falanga: Thank you for this question. For this update, actually, there were two randomized trials addressing the extended thromboprophylaxis in cancer patients. This is an important question, and direct oral anticoagulants had never been included in the previous guidelines. So this new data indicating safety and in some way efficacy of these drugs were important to be in some way included. Actually, the two trials, one tested laparoscopic surgery in patients with colorectal cancer, so major surgery in colorectal cancer and tested the drug rivaroxaban against the placebo after one week of low molecular weight heparin. And the other trial tested in a different type of cancer, gynecological cancer surgery, apixaban versus a placebo after a short course with low molecular weight heparin.  So the two trials are very different, and the recommendation, after all, is weak. But the panel felt it was important to split the previous recommendation 3.5 into three recommendations. The 3.6 specifies which are the cancer patients that really need extended prophylaxis, or the recommendation addresses this population in particular at high risk, which means patients with laparoscopic or laparotomic abdominal pelvic surgery for cancer who have high risk characteristics, including restricted mobility, obesity, previous history of thrombosis, and other additional risk factors. So the recommendation is limited to this population. As I said, there is a weak recommendation because the two trials differ in the type of surgery, the type of the number of patients, the timing of prophylaxis, and one tested rivaroxaban and one tested apixaban. But in any case, the recommendation now reads that prophylaxis with these two direct oral anticoagulants may be offered in addition to the previous recommendation with the low molecular weight heparin for this indication, although the low molecular weight heparin indication remains a strong recommendation where these other two drugs are added. But still other research is needed to strengthen this recommendation. Brittany Harvey: Understood. Thank you for describing where there is evidence and where future research is needed to strengthen those recommendations and the qualifying statements for who is appropriate to receive this VTE prophylaxis. So then, Dr. Key, what did the expert panel update regarding treatment of patients with cancer with established VTE to prevent recurrence?  Dr. Nigel Key: Yes. First of all, I want to make it very clear that this particular recommendation deals, as you say, with patients with established venous thromboembolism. This is quite distinct from recommendations regarding primary prophylaxis in ambulatory patients, which is dealt with in a separate recommendation. That's number two in the 2019 guideline, and those have not been updated. But in terms of treatment of established venous thrombosis, there were three randomized control trials considered. They essentially all addressed the possible role of apixaban, which had not been included in the 2019 guideline. In this revised recommendation, the data looked at both the initial treatment of patients presenting with venous thrombosis as well as extended treatment, which what we know at present, really extends out to six months in terms of using non-vitamin K antagonists, preferably for extended prophylaxis.  So, in 4.1, the CARAVAGGIO trial that I mentioned earlier was a very large trial involving almost 1200 patients with cancer who had symptomatic or incidental acute proximal DVT or pulmonary embolism. And these patients were randomized to six months of treatment with either apixaban or dalteparin. And, in a nutshell, apixaban was non-inferior to dalteparin for the primary outcome of a recurrent VTE during the six month trial period. There was also a similar rate of major bleeding, 3.8 versus 4% in the two arms. So this was strong evidence that initial treatment could include apixaban in addition to what was already in the recommendations. And for those choosing to treat with heparin for initial five to ten days, as before, the recommendation is for low molecular heparin over unfractionated heparin.  So, the second part of this took into account the CARAVAGGIO trial, which I've already mentioned the result of, as well as two smaller trials. They had a VTE trial which had almost 300 patients, and again compared apixaban to dalteparin. And then there was a third smaller study comparing apixaban to lovenox in about 100 patients. But, essentially, the net outcome of the systematic review was that the recommendations 4.1 and 4.2 for, respectively, initial and extended treatment of established VTE, gave high quality evidence with a strong recommendation to include apixaban both for initial treatment and for extended treatment. Brittany Harvey: Understood. So then you've both discussed this a bit by describing the randomized trials supporting these recommendations. But Dr. Falanga, what should clinicians know as they implement these updated recommendations?  Dr. Anna Falanga: Well, clinicians should know that there are more options to offer to their patients for long-term treatment of VTE, as Dr. Key said, up to six months. This is an important expansion of the spectrum of choices for a more personalized treatment on the basis of the patient's characteristics and the drug characteristics. So this is very important to know. Also, for the postoperative prophylaxis, this update is relevant because of the recommendation. Although we are open to the perspective of using new drugs based on oral intake as an alternative to low molecular weight heparin, and knowing this drug appears to be safe in the specific setting where they were tested in the trial is important. Brittany Harvey: Definitely, it's great to have more options for patients. So then in your view, Dr. Key, how will these guideline recommendations impact patients with cancer?  Dr. Nigel Key: Well, I think that with more information that Dr. Falanga just presented, essentially we're looking at two different situations here, both the extended thrombosis prophylaxis after surgery and the choice of agent does need to be individualized with a discussion with a physician. There are still remaining concerns about increased bleeding with direct Xa inhibitors in patients with GI and GU malignancy, for example. So this needs to be taken into account, patients' creatinine values and so on, and what other drugs there are in terms of interactions with direct Xa inhibitors. So I think what you're looking at though is the ability to be confident for that patient that oral agents are, for the most part, as safe and effective as low molecular weight heparins. And hopefully, this will be something that is seen as a positive and maybe somewhat liberating effect for patients.  Brittany Harvey: That's great to hear.  So then finally, Dr. Falanga, you've already mentioned a few areas in which more research would be helpful to strengthen the recommendations. But are there other outstanding questions regarding VTE prophylaxis and treatment in patients with cancer?  Dr. Anna Falanga: Yes, there is a lot of work to be done ahead for prophylaxis. As we already mentioned, it's important to improve the evidence for direct oral anticoagulant safety and efficacy for extended, postoperative prophylaxis. In the medical setting, we have open questions about how to improve the management of patients with VTE beyond six months; we don't know for the treatment of VTE beyond six months, and identify better what are the best drugs and the best strategies to be utilized in this interval.  Then I think that we need to understand, in collaboration with cardiologists and neurologists, whether arterial thrombosis associated with the cancer may need a different treatment compared to subjects without cancer, and understand how to manage anticoagulant together with antiplatelet drugs in these patients who are often thrombocytopenic.  Finally, it is, of course, important to test new drugs for VTE treatment with potentially reduced bleeding risk, such as the new inhibitors of factor XI and factor XII. I think these are the major points that we need to address in the near future possibly.  Brittany Harvey: Absolutely. Well, we'll look forward to future updates of this ASCO guideline to discuss that research as it comes along.  So I want to thank you both so much for your work to update this guideline and thank you for your time today, Dr. Falanga and Dr. Key.  Dr. Anna Falanga: Thanks a lot. Bye bye.  Dr. Nigel Key: Thank you. You're very welcome. Bye bye.  Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/supportive-care-guidelines. You can also find many of our guidelines and interactive resources in the newly redesigned ASCO Guidelines app, available for free in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.  The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.  

Climate-change threatens peri-urban agriculture and food security. This session explores innovative social practices that secure food futures: in Sydney an evolving system connecting urban organic waste to peri-urban agriculture, and in Bologna Italy cooperatives in emerging food solidarity economies. Each case demonstrates how trusting relationships ensure local food futures in urban places. Panel Dr Abby Mellick Lopes, University of Technology Sydney Gabriele Morelli, University of Milan-Bicocca Dr Michelle Zeibots, University of Technology Sydney Dr Stephen Healy, Western Sydney University Chaired by Dr Adrienne Keane, University of Sydney Associate Professor Abby Mellick Lopes is a design studies scholar engaged in interdisciplinary, design-led social research and the Director of Postgraduate Design Studies at UTS. Her research practice brings design into relation with a vast range of disciplines that includes cultural studies, geography, urban studies and sociology. Gabriele Morelli is a PhD Student in Urban Studies at the University of Milan-Bicocca and currently a visiting fellow at the Institute for Culture and Society (Western Sydney University). His ongoing research project is on the transformative potential of Social and Solidarity Economy (SSE) initiatives in a Southern European urban context: the city of Bologna. He has also been active in several grassroots organizations, cooperatives and collectives in Bologna. Michelle Zeibots is a Senior Lecturer in the School of Civil & Environmental Engineering at UTS and transport planner, specialising in the analysis of sustainable urban passenger transport systems. She is also a farmer located in the Lithgow Region in Central NSW where she produces organically grown garlic using regenerative agricultural farming methods that contribute to the circular economy. Stephen Healy is a Senior Research Fellow at the University of Western Sydney's Institute for Culture and Society. His research has concentrated on the relationship between economy, subjectivity and the enactment of new econo-socialities exploring various topics: health care reform policy, cooperative and regional development, and the solidarity economy movement. Adrienne Keane is a Senior Lecturer, researcher and urban planner. Her primary research interest is in the area of statutory land use planning particularly the consequences of policies in nature conservation. Adrienne is a graduate of the Faculty of Architecture, Design and Planning having completed a Master in Urban and Regional Planning and a PhD. Current research falls under the umbrella of protecting natural values in cities.

Debates over the proper approach to the Russo-Ukrainian War have dominated much of the year. Yet discussions within the western left have not always featured the perspectives of Ukrainians and Russians themselves. The Real News Network board member Bill Fletcher, in partnership with Haymarket Books, hosts a panel with Ukrainian and Russian academics.Yuliya Yurchenko is a senior lecturer and researcher in political economy at the Political Economy, Governance, Finance and Accountability Institute and the Economics and International Business Department, the University of Greenwich (UK). She is the author of Ukraine and the Empire of Capital: From Marketisation to Armed Conflict (London: Pluto Press, 2018) and many other publications, including in Capital and Class and New Political Economy. She is vice-chair of the Critical Political Economy Research Network Board (European Sociological Association), co-coordinator of the World Economy working group, IIPPE, and an editor for Capital and Class.Alona Liasheva is a PhD candidate in Urban Studies (URBEUR) at University of Milan-Bicocca focusing on housing in Eastern Europe. She is a co-editor of Commons: Journal for Social Criticism.Ilya Budraitskis writes regularly on politics, art, film and philosophy for e-flux journal, openDemocracy, LeftEast, Colta.ru and other outlets, and teaches at the Moscow School of Social and Economic Sciences and the Institute of Contemporary Art Moscow. The Russian edition of his essay collection Dissidents among Dissidents was awarded the prestigious Andrei Bely prize in 2017.Studio: Dwayne GladdenHelp us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer: Donate: https://therealnews.com/donate-podSign up for our newsletter: https://therealnews.com/newsletter-podLike us on Facebook: https://facebook.com/therealnewsFollow us on Twitter: https://twitter.com/therealnews

With Luigi Badano & Michele Tomaselli, University of Milan Bicocca, Milan - Italy. Link to paper Link to editorial

Dr. Giulio Mattioli conducts research at the Department of Transport Planning at the Technische Universität Dortmund in Germany as the project leader of "Advancing knowledge of long-distance travel: uncovering its connections to mobility biography, migration, and daily travel", funded by Deutsche Forschungsgemeinschaft. Giulio holds a PhD in Urban and Local European Studies from the University of Milan-Bicocca and has published numerous journal articles.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Nicoletta Colombo to discuss pembrolizumab for persistent, recurrent, metastatic cervical cancer: KEYNOTE 826. Professor Nicoletta Colombo graduated in medicine in 1980, completing specialty training in obstetrics and gynaecology in 1984 at the University of Milan, Italy. After a training period at Charing Cross Hospital and Royal Marsden Hospital in London, she became a Clinical Research Associate at the Kaplan Cancer Center, New York University, where she worked from 1984 until 1986. Professor Colombo then worked as a member of the Junior and later the Senior Faculty at the Department of Obstetrics and Gynaecology at the University of Milan. In 1994 she became Deputy Director and in 2001 Director of the Medical Gynaecologic Oncology Division, European Institute of Oncology (IEO), Milan, Italy. Since 2002 she has held the position of Associate Professor of Obstetrics and Gynaecology at the University of Milan-Bicocca. In 2008, she became Director of the Ovarian Cancer Centre at IEO and in 2014 Chair of the Program of Gynaecology. Principal investigators of several international clinical trials, Professor Colombo is also author of several publications in the field of gynaecologic oncology, and a member of various professional societies such as the American Society of Clinical Oncology (ASCO), the Society of Gynaecologic Oncologists (SGO) and the International Gynaecological Cancer Society (IGCS). She is also Past President of the European Society of Gynaecologic Oncology (ESGO) and was Chair of the first ESMO-ESGO-ESTRO Consensus Conference in endometrial cancer ( 2015) and the first ESMO-ESGO Consensus Conference in ovarian Cancer ( 2018). From 2016-2020 she was Subject Editor of ESMO Clinical Guidelines for Gynecological Malignancies and she is currently member of the steering committee of ESMO Clinical guidelines. Highlights 1)adding pembrolizumab to chemotherapy with or without bevacizumab provides statistically significant, clinically meaningful improvements in progression-free and overall survival in patients with persistent, recurrent, or metastatic cervical cancer 2)The addition of pembrolizumab was also associated with a higher response rate and a longer response duration 3)The safety profile for pembrolizumab plus chemotherapy with or without bevacizumab was manageable 4)data from KEYNOTE-826 suggest that pembrolizumab plus platinum-based chemotherapy with or without bevacizumab may be a new first-line standard of care for the treatment of persistent, recurrent, or metastatic cervical cancer.

Les agriculteurs indiens étaient appelés à une journée de grève nationale, ce lundi 27 septembre 2021. Ils réclament toujours l'abrogation des réformes agricoles votées en septembre 2020 et validées, il y a un an jour pour jour, par le président. Il s'agit du plus important et plus long mouvement de contestation depuis l'indépendance de l'Inde, en 1947. Pourtant, le pouvoir refuse toujours de plier. Où en est la mobilisation ? Quelle est la stratégie des autorités ? Et comment peut évoluer le mouvement ?   Décryptage avec :  - Fréderic Landy, professeur de Géographie à l'Université de Paris-Nanterre, et chercheur associé et ancien directeur de l'Institut Français de Pondichéry, Auteur de L'Union indienne et de l'article « L'Inde une agriculture en crise » dans la revue Paysans et société. - Floriane Bolazzi, chercheuse en Socio-Économie à l'Université de Milan-Bicocca, a fait une thèse sur la mobilité sociale en zone rurale en Inde. 

durée : 00:58:33 - Cultures Monde - par : Florian Delorme, Mélanie Chalandon, Antoine Dhulster - Lundi 8 mars, des milliers d'indiennes se sont jointes à la colère des agriculteurs. Ce mouvement massif montre l'investissement des femmes dans la défense des terres. Depuis une trentaine d'années, le milieu agricole s'est considérablement féminisé, que signifie cette implication paysanne en Inde ? - réalisation : Vincent Abouchar, Benjamin Hû - invités : Isabelle Guérin directrice de recherche à l'IRD - Cessma (Centre d'études en sciences sociales sur les mondes américains africains et asiatiques); Floriane Bolazzi chercheuse en socio-économie à l’Université de Milan-Bicocca; Kassia Aleksic doctorante en anthropologie au Centre d’études en sciences sociales sur les mondes africains, américains et asiatiques (CESSMA, Université de Paris)

Young workers and entrepreneurs discuss Pope Francis' economic vision with https://www.newyorkencounter.org/carlos-martinez (Carlos Martínez), CEO of 376 Management Group and https://www.newyorkencounter.org/giorgio-vittadini (Giorgio Vittadini), president of the Foundation for Subsidiarity and professor of statistics at the University of Milan-Bicocca, Italy, moderated by https://www.newyorkencounter.org/anujeet-sareen (Anujeet Sareen), portfolio manager, Brandywine Global An important area in our fragmented society that can easily become prey of ideologies and either facilitate divisions or help to overcome them is the economy. Pope Francis is very passionate about this issue and has recently sent an http://www.vatican.va/content/francesco/en/letters/2019/documents/papa-francesco_20190501_giovani-imprenditori.html (open letter to young men and women studying economics) to "change today's economy and to give a soul to the economy of tomorrow." A different kind of economy "one that brings life not death, one that is inclusive and not exclusive, humane and not dehumanizing, one that cares for the environment and does not despoil it." What does Pope Francis mean by this "different kind of economy"? Can its features be really relevant in the business world? How can they impact and change the everyday working experience of workers and entrepreneurs? Speakers will discuss these questions in a dialogue with young workers and entrepreneurs.

Dr. Giulio Ongaro, currently a postdoctoral fellow in the Economics Department at the University of Milan-Bicocca has just published Peasants and Soldiers: The Management of the Venetian Military Structure in the Mainland Dominion between the 16th and 17th Centuries (Routledge, 2017), a fascinating study of the early modern Venetian military. Rather than focus on the city itself or the republic’s higher-profile naval forces, Ongaro examines the workings of the Venetian land forces—its cavalry, militia, and fortress structures. Financing and supplying these forces required increasingly sophisticated administrative measures that, as in so many European states at the time, drove the expansion of state institutions. Most previous studies have assumed that such expansion came at the expense of local power structures and that state administrations existed in competition with local elites. By examining the records of municipal and rural archives in the Venetian hinterland, Ongaro instead shows that while the central state had the power to make demands, those demands were most often satisfied in cooperation with local forces, rather than in competition. Local elites benefitted from the contracts to provision fortresses or supply saltpeter, for example, and so did not resist state directives as a matter of course. This detailed economic history will expand your horizons and your understanding of early modern military history.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Giulio Ongaro, currently a postdoctoral fellow in the Economics Department at the University of Milan-Bicocca has just published Peasants and Soldiers: The Management of the Venetian Military Structure in the Mainland Dominion between the 16th and 17th Centuries (Routledge, 2017), a fascinating study of the early modern Venetian military. Rather than focus on the city itself or the republic’s higher-profile naval forces, Ongaro examines the workings of the Venetian land forces—its cavalry, militia, and fortress structures. Financing and supplying these forces required increasingly sophisticated administrative measures that, as in so many European states at the time, drove the expansion of state institutions. Most previous studies have assumed that such expansion came at the expense of local power structures and that state administrations existed in competition with local elites. By examining the records of municipal and rural archives in the Venetian hinterland, Ongaro instead shows that while the central state had the power to make demands, those demands were most often satisfied in cooperation with local forces, rather than in competition. Local elites benefitted from the contracts to provision fortresses or supply saltpeter, for example, and so did not resist state directives as a matter of course. This detailed economic history will expand your horizons and your understanding of early modern military history.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Giulio Ongaro, currently a postdoctoral fellow in the Economics Department at the University of Milan-Bicocca has just published Peasants and Soldiers: The Management of the Venetian Military Structure in the Mainland Dominion between the 16th and 17th Centuries (Routledge, 2017), a fascinating study of the early modern Venetian military. Rather than focus on the city itself or the republic's higher-profile naval forces, Ongaro examines the workings of the Venetian land forces—its cavalry, militia, and fortress structures. Financing and supplying these forces required increasingly sophisticated administrative measures that, as in so many European states at the time, drove the expansion of state institutions. Most previous studies have assumed that such expansion came at the expense of local power structures and that state administrations existed in competition with local elites. By examining the records of municipal and rural archives in the Venetian hinterland, Ongaro instead shows that while the central state had the power to make demands, those demands were most often satisfied in cooperation with local forces, rather than in competition. Local elites benefitted from the contracts to provision fortresses or supply saltpeter, for example, and so did not resist state directives as a matter of course. This detailed economic history will expand your horizons and your understanding of early modern military history.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Giulio Ongaro, currently a postdoctoral fellow in the Economics Department at the University of Milan-Bicocca has just published Peasants and Soldiers: The Management of the Venetian Military Structure in the Mainland Dominion between the 16th and 17th Centuries (Routledge, 2017), a fascinating study of the early modern Venetian military. Rather than focus on the city itself or the republic’s higher-profile naval forces, Ongaro examines the workings of the Venetian land forces—its cavalry, militia, and fortress structures. Financing and supplying these forces required increasingly sophisticated administrative measures that, as in so many European states at the time, drove the expansion of state institutions. Most previous studies have assumed that such expansion came at the expense of local power structures and that state administrations existed in competition with local elites. By examining the records of municipal and rural archives in the Venetian hinterland, Ongaro instead shows that while the central state had the power to make demands, those demands were most often satisfied in cooperation with local forces, rather than in competition. Local elites benefitted from the contracts to provision fortresses or supply saltpeter, for example, and so did not resist state directives as a matter of course. This detailed economic history will expand your horizons and your understanding of early modern military history.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Giulio Ongaro, currently a postdoctoral fellow in the Economics Department at the University of Milan-Bicocca has just published Peasants and Soldiers: The Management of the Venetian Military Structure in the Mainland Dominion between the 16th and 17th Centuries (Routledge, 2017), a fascinating study of the early modern Venetian military. Rather than focus on the city itself or the republic’s higher-profile naval forces, Ongaro examines the workings of the Venetian land forces—its cavalry, militia, and fortress structures. Financing and supplying these forces required increasingly sophisticated administrative measures that, as in so many European states at the time, drove the expansion of state institutions. Most previous studies have assumed that such expansion came at the expense of local power structures and that state administrations existed in competition with local elites. By examining the records of municipal and rural archives in the Venetian hinterland, Ongaro instead shows that while the central state had the power to make demands, those demands were most often satisfied in cooperation with local forces, rather than in competition. Local elites benefitted from the contracts to provision fortresses or supply saltpeter, for example, and so did not resist state directives as a matter of course. This detailed economic history will expand your horizons and your understanding of early modern military history.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Giulio Ongaro, currently a postdoctoral fellow in the Economics Department at the University of Milan-Bicocca has just published Peasants and Soldiers: The Management of the Venetian Military Structure in the Mainland Dominion between the 16th and 17th Centuries (Routledge, 2017), a fascinating study of the early modern Venetian military. Rather than focus on the city itself or the republic’s higher-profile naval forces, Ongaro examines the workings of the Venetian land forces—its cavalry, militia, and fortress structures. Financing and supplying these forces required increasingly sophisticated administrative measures that, as in so many European states at the time, drove the expansion of state institutions. Most previous studies have assumed that such expansion came at the expense of local power structures and that state administrations existed in competition with local elites. By examining the records of municipal and rural archives in the Venetian hinterland, Ongaro instead shows that while the central state had the power to make demands, those demands were most often satisfied in cooperation with local forces, rather than in competition. Local elites benefitted from the contracts to provision fortresses or supply saltpeter, for example, and so did not resist state directives as a matter of course. This detailed economic history will expand your horizons and your understanding of early modern military history.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Gianluigi Condorelli, University of Milan-Bicocca, Italy and University of California San Diego, USA, Department of Medicine, National Research Council, Rome, Italy speaks on "New genetic pathways controlling myocardial functions". This seminar has been recorded by ICGEB

Prof. Lavinia Bifulco (Sociology/University of Milan Bicocca)